Search

Author/Creator Prithviraj, Prashanth

1. Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma. Issue 2 (20th November 2020)

Authors:
Atkinson, Victoria; Khattak, Adnan; Haydon, Andrew; Eastgate, Melissa; Roy, Amitesh; Prithviraj, Prashanth; Mueller, Christian; Brignone, Chrystelle; Triebel, Frederic
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells. Issue 1 (December 2016)

Authors:
Jayachandran, Aparna; Lo, Pu-Han; Chueh, Anderly; Prithviraj, Prashanth; Molania, Ramyar; Davalos-Salas, Mercedes; Anaka, Matthew; Walkiewicz, Marzena; Cebon, Jonathan; Behren, Andreas
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy. (4th November 2015)

Authors:
Prithviraj, Prashanth; McArthur, Grant; Atkinson, Victoria; Parente, Phillip; Andrews, Miles; Parakh, Sagun; Millward, Michael; Cebon, Jonathan; Klein, Oliver
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy. Issue 2 (December 2015)

Authors:
Prithviraj, Prashanth; McArthur, Grant; Atkinson, Victoria; Parente, Phillip; Andrews, Miles; Parakh, Sagun; Millward, Michael; Cebon, Jonathan; Klein, Oliver
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗